The Regulatory Landscape of Cell- and Tissue-Based Regenerative Medicine: Current Challenges and Emerging Issues-Reference-Cited by-同舟云学术

The Regulatory Landscape of Cell- and Tissue-Based Regenerative Medicine: Current Challenges and Emerging Issues

Published:2019 Issue: Volume: Page:229-243
ISSN:
Container-title:Regenerative Medicine and Plastic Surgery
language:
Short-container-title:

Author:

Alageel Sarah Khalid,Hildebrandt Martin,de Andrade Ana Valéria Gouveia

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-030-19958-6_22

Reference53 articles.

1. Baptista PM, Atala A. Regenerative medicine: the hurdles and hopes. Transl Res. 2014;163(4):255–8.

2. European Commission. Regulation (EC) No 1394/2007 of the European Parliament and of the Council on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004. 2007. https://ec.europa.eu/health//sites/health/files/files/eudralex/vol-1/reg_2007_1394/reg_2007_1394_en.pdf. Accessed 9 March 2018.

3. European Medicines Agency. Legal Framework. Regulation EC 1394/2007: Europa EU; 2018.

4. Forgó N, Hildebrandt M. Joint conference on the impact of EU legislation on therapeutic advance. Cytotherapy. 2013;15(12):1444–8.

5. Vestergaard HT, Apote LD, Schneider CK, Herberts C. The evolution of nonclinical regulatory science: advanced therapy medicinal products as a paradigm. Mol Ther. 2013;21(9):1294–6.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correction to: The Regulatory Landscape of Cell- and Tissue-Based Regenerative Medicine: Current Challenges and Emerging Issues;Regenerative Medicine and Plastic Surgery;2020